| For: | Qiu Y, Tang Q, Liu XQ, Xue YL, Zeng Y, Hu P. Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure. World J Hepatol 2025; 17(1): 98658 [PMID: 39871916 DOI: 10.4254/wjh.v17.i1.98658] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i1/98658.htm |
| Number | Citing Articles |
| 1 |
Nastaran Arab, Morteza Hosseini. Electrochemical Insights into Bioinorganic Systems. 2026; doi: 10.1039/9781837678945-00235
|
| 2 |
Yuki Nakaya, Takema Hasegawa, Yuji Hoshi, Daichi Onomura, Tomoko Yamagata, Hiroaki Okamoto, Kazumoto Murata, Megumi Kato. Development of a hypersensitive digital ELISA system for hepatitis B core antigen. Analytical and Bioanalytical Chemistry 2026; 418(7) doi: 10.1007/s00216-026-06338-z
|
| 3 |
Kanyakorn Singsung, Athaya Vorasittha, Pisit Tangkijvanich, Yasuhito Tanaka, Natthaya Chuaypen, Pongserath Sirichindakul. Host Factors DDB2 and DNA Polymerase Delta Are Linked to cccDNA Persistence in Hepatitis B Virus and Occult Hepatitis B Virus‐Related Hepatocellular Carcinoma. Journal of Viral Hepatitis 2026; 33(6) doi: 10.1111/jvh.70182
|
| 4 |
Masanori Fukushima, Satoshi Miuma, Yasuhiko Nakao, Ryu Sasaki, Masafumi Haraguchi, Hisamitsu Miyaaki. Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114021
|
| 5 |
Junjie Liu, Tong Yuan, Lin Xue, Huifang Liang. Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D. Virology Journal 2025; 22(1) doi: 10.1186/s12985-025-02907-3
|
| 6 |
Shiyu Wang, Hongxiao Hao, Wen Deng, Lu Zhang, Weihua Cao, Ziyu Zhang, Xinxin Li, Yaqin Zhang, Xin Wei, Linmei Yao, Zixuan Gao, Shuojie Wang, Minghui Li. Predictive value of serum HBcrAg in antiviral therapy for chronic hepatitis B. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1893489
|
| 7 |
Shulin Xia, Xiaomin He, Jianhe Gan, Jiachen Ding. Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues. Infection and Drug Resistance 2025; doi: 10.2147/IDR.S536426
|